Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02831478 · ClinicalTrials.gov registry record · NA
Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
A NA study of Sunscreening Agent, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT02831478: Completed NA study of Sunscreening Agent, sponsored by Bayer.
NCT02831478 is a NA study of Sunscreening Agent that has completed, run by Bayer. The registered enrollment target is 98 participants, above the 11-participant average among 7 other Sunscreening Agent trials with a reported enrollment target (791% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02831478, a NA study of Sunscreening Agent, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the safety of a sunscreen product under supervised outdoor-use conditions with the target consumer
Conditions Studied
Interventions
- DRUG BAY987517
- DRUG Sunscreen Lotion (RB# T78-190B)
Study Locations (1)
Florida
- - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2016-07-09 |
| Est. Completion | 2016-07-10 |
| Phase | NA |
What the finished NCT02831478 record still lists
NCT02831478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, above the 11-participant average among 7 other Sunscreening Agent trials with a reported enrollment target (791% higher).
The record links to 1 condition, with Sunscreening Agent appearing as the primary indexed condition, and to 2 interventions - of which BAY987517 is the first listed.
NCT02831478 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02831478 about?
NCT02831478 is a clinical study titled "Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old". To assess the safety of a sunscreen product under supervised outdoor-use conditions with the target consumer
What is the current status of trial NCT02831478?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2016-07-09. Estimated completion is 2016-07-10.
What conditions does trial NCT02831478 study?
This clinical trial studies the following conditions: Sunscreening Agent.
What interventions are being tested in trial NCT02831478?
The interventions under investigation include: BAY987517 (DRUG), Sunscreen Lotion (RB# T78-190B) (DRUG).
Who is sponsoring clinical trial NCT02831478?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02831478 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agent
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI